Researchers: Want medical student assistance on your project?
The five-month Discovery Phase of the Emory University School of Medicine curriculum provides medical students with the opportunity to conduct hypothesis-driven research projects while working closely with a faculty mentor. If you have a research project that a medical student could assist with, please submit your project information here by
Friday, 8/23. The Office of Research will compile a list of project titles to share with medical students at this year’s Discovery Research Fair on Wednesday, 8/28. Questions Call for applicants! Emory Startup Launch Accelerator program
After a successful 2018 cohort the Emory Startup Launch Accelerator program is now accepting applications from teams for a Fall 2019 cohort. This program, funded by a grant from the Goizueta Creativity and Innovation Initiative, is offered to help early stage founders through a defined process that will help teams rapidly take their ideas and test them with customers to discard, change and build a business model to move the startup forward. View flyer | Read
more NIH policy notices: - Reminders of NIH policies on other support and on policies related to financial conflicts of interest and foreign components: This policy notice reminds the extramural community about the need to report foreign activities through documentation of other support, foreign components, and financial
conflict of interest to prevent scientific, budgetary, or commitment overlap. NIH has long required full transparency for all research activities both domestic and foreign and does not consider these clarifications to be changes in policy. Read more
- Requirement for ORCID iDs for individuals supported by research training, fellowship, research education and career development awards beginning in FY 2020: NIH, AHRQ, and
CDC announce that individuals supported by research training, fellowship, research education, and career development awards will be required to have ORCID iDs (Open Researcher and Contributor Identifiers) beginning in FY 2020. Read more
Need help navigating the Department of Medicine Research Administration Service (RAS) Unit? The DOM RAS Unit has issued a one-page document to assist you in working your way through the grant submission process starting with
pre-award. Download PDF
Research Scientist and Clinical Investigator PATHS:
Whether you are a clinical educator, clinical investigator or research scientist, PATHS will guide you through additional learning opportunities to aid in your career progression. These guidelines detail suggested targeted accomplishments towards promotion with a specific time frame. Each PATH is divided by career year(s) into best practices and academic mission areas. Read more
Funding & Award Opportunities
Weekly NIH funding opportunities and notices
Federal funding opportunities for public health faculty
Searchable database of internal medicine funding opportunities Notices of special interest (NOSI): Health services and economic research on the treatment of drug, alcohol, and tobacco use disorders (R01, R21, R03)
Deadline: Friday 10/4 The purpose of this NOSI is to inform potential applications to the National Institute on Drug Abuse of special interest in grant applications to conduct rigorous health services and economic research to maximize the availability and delivery of efficient, effective drug, alcohol, and tobacco treatment and recovery support services. Read more Biosensors to detect exacerbations of cardiopulmonary disease
This NOSI aims to support the development of bioelectronic sensors, intelligent chemical sensor array systems coupled with bio-receptors, capable of identifying the prodromes of an acute exacerbation in patients with a chronic cardiopulmonary disease. Read more
National Institute on Aging (NIA) program project applications (P01 clinical trial optional)
Deadline: Friday 8/23 (LOI) The NIA invites the submission of investigator-initiated program project (P01) applications addressing scientific areas relevant to the NIA mission. Each application submitted to this FOA must include at least three related research projects that share a common central theme, focus, and/overall objective and an administrative core to lead the project. Read more AGA-Allergan Foundation pilot research award in Inflammatory bowel disease
Deadline: Wednesday 9/4 The objective of this AGA Research Foundation pilot research award is to provide funds for early career investigators to help establish their research careers or to support projects that represent new research directions for established investigators. Read more Pilot projects investigating understudied G protein-coupled receptors, ion channels, and protein kinases (R03 clinical trial not allowed)
Deadline: Friday 9/27 The goal of this FOA for the Common Fund program, “Illuminating the Druggable Genome (IDG)” is to solicit applications for pilot projects on IDG-eligible understudied proteins in order to study them beyond what the IDG’s Centers can accomplish and to validate and demonstrate the utility of IDG-generated reagents, data, and approaches. Read more Specialized alcohol research centers (P50 clinical trial optional)
Deadline: Monday 10/14 This FOA invites applications for specialized Alcohol Research Centers using the P50 mechanism. The overall purpose of the NIAAA Alcohol Research Center program is to provide leadership in conducting and fostering interdisciplinary, collaborative research on a wide variety of topics relevant to the Institute’s mission.
Read more
Comprehensive alcohol research centers (P60 clinical trial optional)
Deadline: Monday 10/14 This FOA invites applications for Comprehensive Alcohol Research Centers using the P60 mechanism which requires a dissemination core to initiate and expand community education related to the activities of the center. The overall purpose of the NIAAA Alcohol Research Center program is to provide leadership in conducting and fostering interdisciplinary, collaborative research on a wide variety of topics relevant to the Institute’s mission. Read more Mechanisms of tolerance (R21/R33 -
Clinical Trial Required)
Deadline: Wednesday 10/16 This FOA focuses on sensitivity and tolerance mechanisms underlying the development of alcohol use disorder. Read more
Kimberly Workowski, Marshall Lyon, Varun Phadke (Infectious Diseases) received funding from Gilead Sciences for a project entitled, "A phase 1b randomized, blinded, placebo-controlled, staggered, single and multiple ascending dose study evaluating the safety, tolerability, and pharmacokinetics of GS-9722 in virologically suppressed HIV-1 infected subjects on antiretroviral therapy." Madeleine Hackney (PI), Molly Perkins (General Medicine and Geriatrics) received an R01 from NIA for a project entitled, "Partnered rhythmic rehabilitation for enhanced motor-cognition in prodromal
Alzheimer's disease." Ruth Parker (General Medicine and Geriatrics) received a subcontract from Northwestern University for a project entitled, "Technology-enables alliance for medication therapy management: the TEAM trial." Have you or a colleague recently received an award or grant funding?
Recent Notable Publications
Puja Mehta and Arshed Quyyumi (Cardiology)
Al-Badri A, Kim JH, Liu C, et al. “Peripheral microvascular function reflects coronary vascular function.” Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1492-1500. Read more
Russel Kempker (Infectious Diseases)
Al-Shaer MH, Alghamdi WA, Alsultan A, An G, Ahmed S, Alkabab Y, Banu S, Barbakadze K, Houpt E, Kipiani M, Mikiashvili L, Cegielski JP, Heysell SK, Peloquin CA, et al. “Fluoroquinolones in grug-resistant tuberculosis: culture conversion and pharmacokinetic/pharmacodynamic target attainment to guide dose selection.” Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00279-19. Read more
Would you like to highlight a recent notable publication?
Zoobiquity Conference: a species-spanning approach to medicine
Friday 9/13 | The Emory Conference Center Hotel | 8 a.m. – 4:30 p.m.
Closing reception at the Atlanta Zoo from 5:30 - 8:30 p.m. The Zoobiquity Conferences bring leaders in human and veterinary medicine, wildlife biology, conservation and evolutionary biology, and behavioral ecology together for collaborations in research, clinical care and public health. These transdisciplinary conferences create greater awareness of the species-spanning nature of health and disease and accelerated biomedical innovation through scientific collaboration between a diverse range of experts in human and animal health. More information | Register
Save the Date: 12th Annual Department of Medicine Research Day
Friday, 11/1 | Cox Hall Ballroom | 7:30 a.m. - 5 p.m.
This full-day program includes both oral and poster presentations as well as a keynote address from Gary Gibbons, MD, Director, National Heart, Lung, and Blood Institute at the National Institutes of Health.
Sam Lim, MD, MPH
Division of Rheumatology
What is your professional background?
I received a degree in chemistry from Duke University and my medical degree from the State University of New York. I did my internal medicine residency and rheumatology fellowship at Emory University, during which I got a MPH in epidemiology from the Rollins School of Public Health.
In what division do you work, and who is your mentor?
I am in the Division of Rheumatology, Department of Medicine, with a joint appointment in the Department of Epidemiology at Rollins.
Briefly describe your research. Why is it important?
My research interests are in epidemiology, outcomes, and contributions of social determinants of health in lupus disparities. I am a Principal Investigator for The Georgia Lupus Registry (GLR), one of the Centers for Disease Control and Prevention (CDC)-funded population-based lupus registries from which I helped create the Georgians Organized Against Lupus (GOAL) research cohort that now has over 1,100 consented individuals with a validated diagnosis of lupus from the Atlanta metropolitan area. I am currently funded by the NIH and the CDC to study the role of psychosocial stressors and other social determinants of health on racial health disparities in lupus. Lupus disproportionately afflicts young women and minorities, especially those of African ancestry. What do
you like most about Emory?
I love being able to serve the people at Grady while advancing lupus research there through the Grady Lupus Clinic and our affiliated research studies. Emory and Grady are powerfully complementary and a combined resource that has few equals. What do you like to do in your spare time?
I love to run while listening to a good audiobook and watching my children grow into amazing individuals.
"What's Up" is brought to you by the Emory University Department of Medicine's Research Community.
View the DOM Research website here.
|